protein

Ephrin-B2/EFNB2 Protein, Canine (HEK293, His)

HY-P75230

2 μg;10 μg;50 μg;100 μg

35;60;165;280 USD

Ephrin-B2/EFNB2 Protein, Canine (HEK293, His)

proteins

HEK293

2 μg;10 μg;50 μg;100 μg

35;60;165;280 USD

Ephrin-B2/EFNB2 Protein, a member of the ephrin family, serves as a transmembrane ligand, interacting with its Eph receptor to initiate bidirectional signaling. Crucial in developmental processes like tissue boundary formation, axon guidance, angiogenesis, and synaptic plasticity, Ephrin-B2/EFNB2 is implicated in conditions like cancer, cardiovascular diseases, and neurological disorders, making it a potential therapeutic target. Ephrin-B2/EFNB2 Protein, Canine (HEK293, His) is the recombinant canine-derived Ephrin-B2/EFNB2 protein, expressed by HEK293 , with C-His labeled tag. The total length of Ephrin-B2/EFNB2 Protein, Canine (HEK293, His) is 202 a.a., with molecular weight of ~25-35 kDa.

Canine

Ephrin-B2/EFNB2 protein is a member of the ephrin family, a group of proteins that play important roles in cellular signaling and communication. Ephrin-B2/EFNB2 specifically functions as a transmembrane ligand, interacting with its corresponding Eph receptor to initiate bidirectional signaling events that regulate diverse cellular processes. This protein is involved in various developmental processes, including tissue boundary formation, axon guidance, angiogenesis, and synaptic plasticity. Additionally, Ephrin-B2/EFNB2 has been implicated in pathological conditions such as cancer, cardiovascular diseases, and neurological disorders, making it a potential therapeutic target for intervention.

Ephrin-B2; LERK-5; HTK-L; EFNB2; EPLG5

Greater than 95% as determined by reducing SDS-PAGE.

Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.

Room temperature in continental US; may vary elsewhere.